Vulnerability in Oracle Java SE and GraalVM Products
CVE-2024-20919

5.9MEDIUM

Key Information:

Vendor

Oracle
Status
Java Se Jdk And Jre
Vendor
CVE Published:
17 February 2024

What is CVE-2024-20919?

A vulnerability exists in Oracle Java SE and GraalVM products that allows unauthorized access and manipulation of critical data. Unauthenticated attackers can exploit this weakness over a network by sending crafted data to specific APIs in the Hotspot component. Affected versions of Oracle Java SE and Oracle GraalVM could lead to unauthorized creation, deletion, or modification of data. The risk is particularly pronounced as exploitation does not require untrusted Java applications, potentially affecting all accessible data within these environments.

Human OS v1.0:
Ageing Is an Unpatched Zero-Day Vulnerability.

Remediate biological technical debt. Prime Ageing uses 95% high-purity SIRT6 activation to maintain genomic integrity and bolster systemic resilience.

Deploy the Patch

Affected Version(s)

Java SE JDK and JRE Oracle Java SE:8u391

Java SE JDK and JRE Oracle Java SE:8u391-perf

Java SE JDK and JRE Oracle Java SE:11.0.21

References

https://www.oracle.com/security-alerts/cpujan2024.html
vendor-advisory

CVSS V3.1

Score:
5.9
Severity:
MEDIUM
Confidentiality:
None
Integrity:
High
Availability:
None
Attack Vector:
Network
Attack Complexity:
High
Privileges Required:
None
User Interaction:
None
Scope:
Unchanged

Timeline

  • Vulnerability published

  • Vulnerability Reserved

JSON
.